Crit Ventures USA

Crit Ventures USA is a venture capital firm headquartered in Seoul, South Korea, specializing in investments across seed, early, and late-stage technology companies. The firm focuses on sectors such as technology, entertainment, blockchain, FinTech, software, media, music, games, platform, AI, commerce, bio, pet pharmaceuticals, and autonomous robotics. Crit Ventures has a diverse geographical focus, including South Korea, the United States, Japan, China, and Saudi Arabia.

The firm's investment strategy emphasizes global expansion and innovation in various industries, aiming to support startups that combine industrial competitiveness with new technologies and business models. Crit Ventures has made significant investments in companies like Neubility, a leader in autonomous robotics, and Petpharm, a pet pharmaceutical distributor. In 2024, Crit Ventures executed 25 investments totaling 25.1 billion KRW, with a notable focus on K-content sectors and new technologies. The firm's assets under management total 260 billion KRW, combining 224 billion KRW in Korea and 36 billion KRW globally.

Crit Ventures is led by CEO Jaejoon Song, who previously served as CEO of Com2uS and is currently the Global Chief Investment Officer of the Com2uS Group. The firm's investment philosophy centers on identifying and nurturing high-impact, technology-driven solutions that have the potential to lead in their respective markets. By leveraging its extensive network and expertise, Crit Ventures aims to foster the growth of innovative companies on a global scale.